Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
1.940
0.00 (0.00%)
At close: Nov 4, 2024, 4:00 PM
1.860
-0.080 (-4.12%)
After-hours: Nov 4, 2024, 6:24 PM EST
Stereotaxis Employees
Stereotaxis had 122 employees as of December 31, 2023. The number of employees decreased by 8 or -6.15% compared to the previous year.
Employees
122
Change (1Y)
-8
Growth (1Y)
-6.15%
Revenue / Employee
$194,639
Profits / Employee
-$181,000
Market Cap
167.11M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
The Joint | 794 |
biote | 194 |
BrainsWay | 134 |
Black Diamond Therapeutics | 54 |
Candel Therapeutics | 42 |
Achieve Life Sciences | 22 |
Skye Bioscience | 11 |
Sagimet Biosciences | 10 |
STXS News
- 14 days ago - Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation - GlobeNewsWire
- 2 months ago - Stereotaxis to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress - GlobeNewsWire
- 2 months ago - Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval - Seeking Alpha
- 3 months ago - Stereotaxis, Inc. (STXS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Stereotaxis Reports 2024 Second Quarter Financial Results - GlobeNewsWire
- 3 months ago - Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX - GlobeNewsWire
- 3 months ago - Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024 - GlobeNewsWire